Mycoplasma Testing Market Size, Share & Trends Analysis By Product (Instruments, Kit & Reagents), By Technology (PCR, ELISA), By Application (Cell Line Testing, Virus Testing), By End Use, Region And Segment Forecasts, 2022 - 2030
This report can be delivered to the clients within 3 Business Days
Mycoplasma Testing Market Growth & Trends
The global mycoplasma testing market size is expected to reach USD 2.2 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 13.2% from 2022 to 2030. The major factors driving the expansion of market includes growing demand for mycoplasma testing in biomanufacturing, emerging economies, and growing pharmaceutical outsourcing. Additionally, the market's overall growth is driven by rising cell-line contamination and innovation & research in biological sciences.
Growing number of government initiatives to support pharmaceutical and biotechnology companies is also driving the market growth. The U.S. FDA proposed to remove a test for detecting mycoplasma within in vitro living cell cultures, as it can help identify only a single test method. These changes in biologics regulations are anticipated to improve specificity and sensitivity in mycoplasma detection tests, leading to introduction of new technologies in the industry. This is expected to create immense opportunities for key players in new product development.
The rates of M. pneumoniae positivity sharply decreased during the COVID-19 pandemic outbreak at the end of 2019. This was a result of the COVID-19 pandemic's stringent regulations, which successfully stopped the spread of M. pneumonia. However, it is anticipated that M. pneumonia will expand even more throughout the research period following the relaxation of COVID-19 limits, which will have a positive impact on the mycoplasma testing market's growth.
Increasing investments in R&D have contributed significantly to the market’s revenue growth. With rising healthcare expenditure, research activities in the life sciences industry are increasing significantly. The adoption of new technologies for drug discovery & development and innovations in cell culture technologies are driving the demand for mycoplasma tests. The high risk of cell culture contamination remains the primary factor expected to drive the mycoplasma testing market over the forecast period
Mycoplasma is estimated to contaminate around 15%-35% of all continuous cell cultures around the world. Out of over 190 known species of mycoplasma, only eight species are responsible for more than 95% of cell culture contamination. Poor cultural practices, aerosols, dust, and cross-contamination as a result of faulty or broken laminar flow are some of the factors responsible for an increase in the number of cell culture contamination events. Such factors are likely to drive the market demand for mycoplasma testing solutions.
Mycoplasma Testing Market Report Highlights
Mycoplasma Testing Market Growth & Trends
The global mycoplasma testing market size is expected to reach USD 2.2 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 13.2% from 2022 to 2030. The major factors driving the expansion of market includes growing demand for mycoplasma testing in biomanufacturing, emerging economies, and growing pharmaceutical outsourcing. Additionally, the market's overall growth is driven by rising cell-line contamination and innovation & research in biological sciences.
Growing number of government initiatives to support pharmaceutical and biotechnology companies is also driving the market growth. The U.S. FDA proposed to remove a test for detecting mycoplasma within in vitro living cell cultures, as it can help identify only a single test method. These changes in biologics regulations are anticipated to improve specificity and sensitivity in mycoplasma detection tests, leading to introduction of new technologies in the industry. This is expected to create immense opportunities for key players in new product development.
The rates of M. pneumoniae positivity sharply decreased during the COVID-19 pandemic outbreak at the end of 2019. This was a result of the COVID-19 pandemic's stringent regulations, which successfully stopped the spread of M. pneumonia. However, it is anticipated that M. pneumonia will expand even more throughout the research period following the relaxation of COVID-19 limits, which will have a positive impact on the mycoplasma testing market's growth.
Increasing investments in R&D have contributed significantly to the market’s revenue growth. With rising healthcare expenditure, research activities in the life sciences industry are increasing significantly. The adoption of new technologies for drug discovery & development and innovations in cell culture technologies are driving the demand for mycoplasma tests. The high risk of cell culture contamination remains the primary factor expected to drive the mycoplasma testing market over the forecast period
Mycoplasma is estimated to contaminate around 15%-35% of all continuous cell cultures around the world. Out of over 190 known species of mycoplasma, only eight species are responsible for more than 95% of cell culture contamination. Poor cultural practices, aerosols, dust, and cross-contamination as a result of faulty or broken laminar flow are some of the factors responsible for an increase in the number of cell culture contamination events. Such factors are likely to drive the market demand for mycoplasma testing solutions.
Mycoplasma Testing Market Report Highlights
- By product, kits and reagents dominated the market, and are anticipated to exhibit the fastest CAGR throughout the forecast period, due to their widespread use in mycoplasma testing
- By technology, the polymerase chain reaction segment held a larger share in 2021 which can be attributed to the technology's ability to give quick and precise findings
- Ease of conducting the procedure and rapid detection are some of the major advantages offered by the PCR method
- By application, the cell line testing segment held a larger share in 2021. the increasing risk of cell line contamination
- Mycoplasma contamination can cause alterations in cell culture metabolites and lead to development of toxins. This increases the importance of cell line testing and authentication in the pharmaceutical and biopharmaceutical industries
- North America held the larger share in 2021. This is mostly attributed to the presence of significant market participants, as well as rising R&D spending and federal assistance
- In Asia Pacific, the market is expected to grow at the highest rate in a projected time period driven by factors such as the rising prevalence of target diseases with an aging population, rising awareness and others
CHAPTER 1 METHODOLOGY AND SCOPE
1.1 Research Methodology
1.2 Research Assumptions
1.2.1 Estimates And Forecast Timeline
1.3 Information Procurement
1.3.1 Purchased Database
1.3.2 Gvr’s Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.3.5 Details Of Primary Research
1.4 Information Or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Research Methodology:
1.6.1 Market Estimation For Mycoplasma Testing Market
1.6.2 Commodity Flow Analysis (Model 1)
1.6.3 Volume Price Analysis (Model 2)
1.6.3.1 Approach 2: Volume Price Analysis
1.7 Objectives
1.7.1 Objective 1:
1.7.2 Objective 2:
CHAPTER 2 EXECUTIVE SUMMARY
2.1 Market Outlook
2.2 Segment Outlook
2.3 Competitive Insights
CHAPTER 3 MARKET VARIABLES, TRENDS, & SCOPE
3.1 Market Lineage Outlook
3.1.1 Parent Market Outlook
3.1.2 Related/Ancillary Market Outlook
3.2 Penetration & Growth Prospect Mapping
3.2.1 Key Opportunities Prioritized, By Product
3.2.2 Key Opportunities Prioritized, By Technology
3.2.3 Key Opportunities Prioritized, By Application
3.2.4 Key Opportunities Prioritized, By End-Use
3.3 Market Dynamics
3.3.1 Market Driver Analysis
3.3.1.1 Increasing R&D Investments In Life Sciences
3.3.1.2 Rising Government Support For Pharmaceutical And Biotechnology Industries
3.3.1.3 Rising Cell Culture Contamination
3.3.1.4 Growing Demand For The Introduction Of Effective Treatment Of Life-Threatening Diseases
3.3.2 Market Restraint Analysis
3.3.2.1 High Cost Of Research In Cell Biology
3.3.2.2 Slow Rate Of Mycoplasma Growth
3.3.3 Industry Challenges
3.3.3.1 Possibility of false-negative results
3.3.4 Market Opportunity Analysis
3.3.4.1 Increasing Need For Mycoplasma Quality Control For Cell Substrates And Biopharmaceuticals
3.4 Mycoplasma Testing: Market Analysis Tools
3.4.1 Industry Analysis - Porter’s
3.4.2 Mycoplasma Testing - Swot Analysis, By Factor (Political & Legal, Economic And Technological)
3.4.3 Major Deals & Strategic Alliances Analysis
3.4.4 Market Entry Strategies
3.5 Covid-19 Impact Analysis
CHAPTER 4 PRODUCT BUSINESS ANALYSIS
4.1 Mycoplasma Testing Market-Product Movement Analysis
4.2 Instruments
4.2.1 Global Instruments Market, 2018 - 2030 (USD Million)
4.3 Kits & Reagents
4.3.1 Global Kits & Reagents Market, 2018 - 2030 (USD Million)
4.3.2 PCR Assays
4.3.2.1 Global PCR Assays Market, 2018 - 2030 (USD Million)
4.3.3 Nucleic Acid Detection Kits
4.3.3.1 Global Nucleic Acid Detection Kits Market, 2018 - 2030 (USD Million)
4.3.4 Stains
4.3.4.1 Global Stains Market, 2018 - 2030 (USD Million)
4.3.5 Elimination Kits
4.3.5.1 Global Elimination Kits Market, 2018 - 2030 (USD Million)
4.3.6 Standards & Controls
4.3.6.1 Global Standards & Controls Market, 2018 - 2030 (USD Million)
4.3.7 Others
4.3.7.1 Global Other Kits & Reagents Market, 2018 - 2030 (USD Million)
4.4 Services
4.4.1 Global Services Market, 2018 - 2030 (USD Million)
CHAPTER 5 TECHNOLOGY BUSINESS ANALYSIS
5.1 Mycoplasma Testing Market-Technology Movement Analysis
5.2 PCR
5.2.1 Global PCR Market, 2018 - 2030 (USD Million)
5.3 Elisa
5.3.1 Global Elisa Market, 2018 - 2030 (USD Million)
5.4 Direct Assays
5.4.1 Global Direct Assays Market, 2018 - 2030 (USD Million)
5.5 Indirect Assays
5.5.1 Global Indirect Assays Market, 2018 - 2030 (USD Million)
5.6 Microbial Culture Techniques
5.6.1 Global Microbial Culture Techniques Market, 2018 - 2030 (USD Million)
5.7 Enzymatic Methods
5.7.1 Global Enzymatic Methods Market, 2018 - 2030 (USD Million)
CHAPTER 6 APPLICATION BUSINESS ANALYSIS
6.1 Mycoplasma Testing Market-Application Movement Analysis
6.2 Cell Line Testing
6.2.1 Global Cell Line Testing Market, 2018 - 2030 (USD Million)
6.3 Virus Testing
6.3.1 Global Virus Testing Market, 2018 - 2030 (USD Million)
6.4 End-Of-Production Cell Testing
6.4.1 Global End-Of-Production Cell Testing Market, 2018 - 2030 (USD Million)
6.5 Others
6.5.1 Global Other Applications Market, 2018 - 2030 (USD Million)
CHAPTER 7 END-USE BUSINESS ANALYSIS
7.1 Mycoplasma Testing Market-End-Use Movement Analysis
7.2 Pharmaceutical & Biotechnology Companies
7.2.1 Global Mycoplasma Testing Market For Pharmaceutical & Biotechnology Companies, 2018 - 2030 (USD Million)
7.3 Cell Banks
7.3.1 Global Mycoplasma Testing Market For Cell Banks, 2018 - 2030 (USD Million)
7.4 Contract Research Organizations (CROS)
7.4.1 Global Mycoplasma Testing Market For Contract Research Organizations (CROS), 2018 - 2030 (USD Million)
7.5 Academic & Research Institutes
7.5.1 Global Mycoplasma Testing Market For Academic & Research Institutes, 2018 - 2030 (USD Million)
7.6 Others
7.6.1 Global Mycoplasma Testing Market For Other End-Use, 2018 - 2030 (USD Million)
CHAPTER 8 REGIONAL BUSINESS ANALYSIS
8.1 Mycoplasma Testing Market: Regional Movement Analysis
8.2 North America
8.2.1 North America Swot Analysis
8.2.2 North America Mycoplasma Testing Market, 2018 - 2030 (USD Million)
8.2.3 U.S.
8.2.3.1 U.S. Mycoplasma Testing Market, 2018 - 2030 (USD Million)
8.2.4 Canada
8.2.4.1 Canada Mycoplasma Testing Market, 2018 - 2030 (USD Million)
8.3 Europe
8.3.1 Europe Swot Analysis
8.3.2 Europe Mycoplasma Testing Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.3.3 Germany
8.3.3.1 Germany Mycoplasma Testing Market, 2018 - 2030 (USD Million)
8.3.4 UK
8.3.4.1 UK Mycoplasma Testing Market, 2018 - 2030 (USD Million)
8.3.5 France
8.3.5.1 France Mycoplasma Testing Market, 2018 - 2030 (USD Million)
8.3.6 Italy
8.3.6.1 Italy Mycoplasma Testing Market, 2018 - 2030 (USD Million)
8.3.7 Spain
8.3.7.1 Spain Mycoplasma Testing Market, 2018 - 2030 (USD Million)
8.3.8 Russia
8.3.8.1 Russia Mycoplasma Testing Market, 2018 - 2030 (USD Million)
8.3.9 Rest of Europe
8.3.9.1 Rest of Europe Mycoplasma Testing Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.4 Asia Pacific
8.4.1 Asia Pacific Swot Analysis
8.4.2 Asia Pacific Mycoplasma Testing, 2018 - 2030 (USD Million)
8.4.3 Japan
8.4.3.1 Japan Mycoplasma Testing Market, 2018 - 2030 (USD Million)
8.4.4 China
8.4.4.1 China Mycoplasma Testng Market, 2018 - 2030 (USD Million)
8.4.5 India
8.4.5.1 India Mycoplasma Testing Market, 2018 - 2030 (USD Million)
8.4.6 South Korea
8.4.6.1 South Korea Mycoplasma Testing Market, 2018 - 2030 (USD Million)
8.4.7 Australia
8.4.7.1 Australia Mycoplasma Testing Market, 2018 - 2030 (USD Million)
8.4.8 Singapore
8.4.8.1 Singapore Mycoplasma Testing Market, 2018 - 2030 (USD Million)
8.4.9 Rest of APAC
8.4.9.1 Rest of APAC Mycoplasma Testing Market, 2018 - 2030 (USD Million)
8.5 Latin America
8.5.1 Latin America Swot Analysis
8.5.2 Latin America Mycoplasma Testing Market, 2018 - 2030 (USD Million)
8.5.3 Brazil
8.5.3.1 Brazil Mycoplasma Testing Market, 2018 - 2030 (USD Million)
8.5.4 Mexico
8.5.4.1 Mexico Mycoplasma Testing Market, 2018 - 2030 (USD Million)
8.5.5 Argentina
8.5.5.1 Argentina Mycoplasma Testing Market, 2018 - 2030 (USD Million)
8.5.6 Rest of Latam
8.5.6.1 Rest of Latam Mycoplasma Testing Market, 2018 - 2030 (USD Million)
8.6 Middle East & Africa (MEA)
8.6.1 Middle East & Africa Swot Analysis
8.6.2 MEA Mycoplasma Testing Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.6.3 South Africa
8.6.3.1 South Africa Mycoplasma Testing Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.6.4 Saudi Arabia
8.6.4.1 Saudi Arabia Mycoplasma Testing Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.6.5 UAE
8.6.5.1 UAE Mycoplasma Testing Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.6.6 Rest of MEA
8.6.6.1 Rest of MEA Mycoplasma Testing Market Estimates And Forecast, 2018 - 2030 (USD Million)
CHAPTER 9 COMPETITIVE LANDSCAPE
9.1 Recent Developments & Impact Analysis, By Key Market Participants
9.2 Company Categorization
9.3 Vendor Landscape
9.3.1 List Of Key Distributors And Channel Partners
9.3.2 Company Market Share Analysis
9.4 Public Companies
9.4.1 Company Market Position Analysis
9.5 Private Companies
9.5.1 List Of Key Emerging Companies
9.5.2 Company Market Position Analysis
9.6 Regional Network Map
9.7 Company Profiles
9.7.1 THERMO FISHER SCIENTIFIC, INC.
9.7.1.1 Company overview
9.7.1.2 Financial performance
9.7.1.3 Product benchmarking
9.7.1.4 Strategic initiatives
9.7.2 MERCK KGAA
9.7.2.1 Company overview
9.7.2.2 Millipore Sigma
9.7.2.2.1 Company overview
9.7.2.3 Financial performance
9.7.2.4 Product benchmarking
9.7.2.5 Strategic initiatives
9.7.3 LONZA GROUP AG
9.7.3.1 Company overview
9.7.3.2 Financial performance
9.7.3.3 Product benchmarking
9.7.3.4 Strategic Initiatives
9.7.4 CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
9.7.4.1 Company overview
9.7.4.2 Financial performance
9.7.4.3 Product benchmarking
9.7.4.4 Strategic initiatives
9.7.5 PROMOCELL GMBH
9.7.5.1 Company overview
9.7.5.2 Product benchmarking
9.7.6 AMERICAN TYPE CULTURE COLLECTION
9.7.6.1 Company overview
9.7.6.2 Product benchmarking
9.7.6.3 Strategic initiatives
9.7.7 ASAHI KASEI MEDICAL CO., LTD.
9.7.7.1 Company overview
9.7.7.2 Bionique Testing Laboratories LLC
9.7.7.2.1 Company overview
9.7.7.2.2 Product benchmarking
9.7.7.2.3 Strategic initiatives
9.7.8 SARTORIUS AG
9.7.8.1 Company overview
9.7.8.2 Financial Performance
9.7.8.3 Product benchmarking
9.7.8.4 Strategic initiatives
9.7.9 INVIVOGEN
9.7.9.1 Company overview
9.7.9.2 Product benchmarking
9.7.10 EUROFINS SCIENTIFIC
9.7.10.1 Company overview
9.7.10.2 Financial Performance
9.7.10.3 Product benchmarking
9.7.10.4 Strategic initiatives
1.1 Research Methodology
1.2 Research Assumptions
1.2.1 Estimates And Forecast Timeline
1.3 Information Procurement
1.3.1 Purchased Database
1.3.2 Gvr’s Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.3.5 Details Of Primary Research
1.4 Information Or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Research Methodology:
1.6.1 Market Estimation For Mycoplasma Testing Market
1.6.2 Commodity Flow Analysis (Model 1)
1.6.3 Volume Price Analysis (Model 2)
1.6.3.1 Approach 2: Volume Price Analysis
1.7 Objectives
1.7.1 Objective 1:
1.7.2 Objective 2:
CHAPTER 2 EXECUTIVE SUMMARY
2.1 Market Outlook
2.2 Segment Outlook
2.3 Competitive Insights
CHAPTER 3 MARKET VARIABLES, TRENDS, & SCOPE
3.1 Market Lineage Outlook
3.1.1 Parent Market Outlook
3.1.2 Related/Ancillary Market Outlook
3.2 Penetration & Growth Prospect Mapping
3.2.1 Key Opportunities Prioritized, By Product
3.2.2 Key Opportunities Prioritized, By Technology
3.2.3 Key Opportunities Prioritized, By Application
3.2.4 Key Opportunities Prioritized, By End-Use
3.3 Market Dynamics
3.3.1 Market Driver Analysis
3.3.1.1 Increasing R&D Investments In Life Sciences
3.3.1.2 Rising Government Support For Pharmaceutical And Biotechnology Industries
3.3.1.3 Rising Cell Culture Contamination
3.3.1.4 Growing Demand For The Introduction Of Effective Treatment Of Life-Threatening Diseases
3.3.2 Market Restraint Analysis
3.3.2.1 High Cost Of Research In Cell Biology
3.3.2.2 Slow Rate Of Mycoplasma Growth
3.3.3 Industry Challenges
3.3.3.1 Possibility of false-negative results
3.3.4 Market Opportunity Analysis
3.3.4.1 Increasing Need For Mycoplasma Quality Control For Cell Substrates And Biopharmaceuticals
3.4 Mycoplasma Testing: Market Analysis Tools
3.4.1 Industry Analysis - Porter’s
3.4.2 Mycoplasma Testing - Swot Analysis, By Factor (Political & Legal, Economic And Technological)
3.4.3 Major Deals & Strategic Alliances Analysis
3.4.4 Market Entry Strategies
3.5 Covid-19 Impact Analysis
CHAPTER 4 PRODUCT BUSINESS ANALYSIS
4.1 Mycoplasma Testing Market-Product Movement Analysis
4.2 Instruments
4.2.1 Global Instruments Market, 2018 - 2030 (USD Million)
4.3 Kits & Reagents
4.3.1 Global Kits & Reagents Market, 2018 - 2030 (USD Million)
4.3.2 PCR Assays
4.3.2.1 Global PCR Assays Market, 2018 - 2030 (USD Million)
4.3.3 Nucleic Acid Detection Kits
4.3.3.1 Global Nucleic Acid Detection Kits Market, 2018 - 2030 (USD Million)
4.3.4 Stains
4.3.4.1 Global Stains Market, 2018 - 2030 (USD Million)
4.3.5 Elimination Kits
4.3.5.1 Global Elimination Kits Market, 2018 - 2030 (USD Million)
4.3.6 Standards & Controls
4.3.6.1 Global Standards & Controls Market, 2018 - 2030 (USD Million)
4.3.7 Others
4.3.7.1 Global Other Kits & Reagents Market, 2018 - 2030 (USD Million)
4.4 Services
4.4.1 Global Services Market, 2018 - 2030 (USD Million)
CHAPTER 5 TECHNOLOGY BUSINESS ANALYSIS
5.1 Mycoplasma Testing Market-Technology Movement Analysis
5.2 PCR
5.2.1 Global PCR Market, 2018 - 2030 (USD Million)
5.3 Elisa
5.3.1 Global Elisa Market, 2018 - 2030 (USD Million)
5.4 Direct Assays
5.4.1 Global Direct Assays Market, 2018 - 2030 (USD Million)
5.5 Indirect Assays
5.5.1 Global Indirect Assays Market, 2018 - 2030 (USD Million)
5.6 Microbial Culture Techniques
5.6.1 Global Microbial Culture Techniques Market, 2018 - 2030 (USD Million)
5.7 Enzymatic Methods
5.7.1 Global Enzymatic Methods Market, 2018 - 2030 (USD Million)
CHAPTER 6 APPLICATION BUSINESS ANALYSIS
6.1 Mycoplasma Testing Market-Application Movement Analysis
6.2 Cell Line Testing
6.2.1 Global Cell Line Testing Market, 2018 - 2030 (USD Million)
6.3 Virus Testing
6.3.1 Global Virus Testing Market, 2018 - 2030 (USD Million)
6.4 End-Of-Production Cell Testing
6.4.1 Global End-Of-Production Cell Testing Market, 2018 - 2030 (USD Million)
6.5 Others
6.5.1 Global Other Applications Market, 2018 - 2030 (USD Million)
CHAPTER 7 END-USE BUSINESS ANALYSIS
7.1 Mycoplasma Testing Market-End-Use Movement Analysis
7.2 Pharmaceutical & Biotechnology Companies
7.2.1 Global Mycoplasma Testing Market For Pharmaceutical & Biotechnology Companies, 2018 - 2030 (USD Million)
7.3 Cell Banks
7.3.1 Global Mycoplasma Testing Market For Cell Banks, 2018 - 2030 (USD Million)
7.4 Contract Research Organizations (CROS)
7.4.1 Global Mycoplasma Testing Market For Contract Research Organizations (CROS), 2018 - 2030 (USD Million)
7.5 Academic & Research Institutes
7.5.1 Global Mycoplasma Testing Market For Academic & Research Institutes, 2018 - 2030 (USD Million)
7.6 Others
7.6.1 Global Mycoplasma Testing Market For Other End-Use, 2018 - 2030 (USD Million)
CHAPTER 8 REGIONAL BUSINESS ANALYSIS
8.1 Mycoplasma Testing Market: Regional Movement Analysis
8.2 North America
8.2.1 North America Swot Analysis
8.2.2 North America Mycoplasma Testing Market, 2018 - 2030 (USD Million)
8.2.3 U.S.
8.2.3.1 U.S. Mycoplasma Testing Market, 2018 - 2030 (USD Million)
8.2.4 Canada
8.2.4.1 Canada Mycoplasma Testing Market, 2018 - 2030 (USD Million)
8.3 Europe
8.3.1 Europe Swot Analysis
8.3.2 Europe Mycoplasma Testing Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.3.3 Germany
8.3.3.1 Germany Mycoplasma Testing Market, 2018 - 2030 (USD Million)
8.3.4 UK
8.3.4.1 UK Mycoplasma Testing Market, 2018 - 2030 (USD Million)
8.3.5 France
8.3.5.1 France Mycoplasma Testing Market, 2018 - 2030 (USD Million)
8.3.6 Italy
8.3.6.1 Italy Mycoplasma Testing Market, 2018 - 2030 (USD Million)
8.3.7 Spain
8.3.7.1 Spain Mycoplasma Testing Market, 2018 - 2030 (USD Million)
8.3.8 Russia
8.3.8.1 Russia Mycoplasma Testing Market, 2018 - 2030 (USD Million)
8.3.9 Rest of Europe
8.3.9.1 Rest of Europe Mycoplasma Testing Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.4 Asia Pacific
8.4.1 Asia Pacific Swot Analysis
8.4.2 Asia Pacific Mycoplasma Testing, 2018 - 2030 (USD Million)
8.4.3 Japan
8.4.3.1 Japan Mycoplasma Testing Market, 2018 - 2030 (USD Million)
8.4.4 China
8.4.4.1 China Mycoplasma Testng Market, 2018 - 2030 (USD Million)
8.4.5 India
8.4.5.1 India Mycoplasma Testing Market, 2018 - 2030 (USD Million)
8.4.6 South Korea
8.4.6.1 South Korea Mycoplasma Testing Market, 2018 - 2030 (USD Million)
8.4.7 Australia
8.4.7.1 Australia Mycoplasma Testing Market, 2018 - 2030 (USD Million)
8.4.8 Singapore
8.4.8.1 Singapore Mycoplasma Testing Market, 2018 - 2030 (USD Million)
8.4.9 Rest of APAC
8.4.9.1 Rest of APAC Mycoplasma Testing Market, 2018 - 2030 (USD Million)
8.5 Latin America
8.5.1 Latin America Swot Analysis
8.5.2 Latin America Mycoplasma Testing Market, 2018 - 2030 (USD Million)
8.5.3 Brazil
8.5.3.1 Brazil Mycoplasma Testing Market, 2018 - 2030 (USD Million)
8.5.4 Mexico
8.5.4.1 Mexico Mycoplasma Testing Market, 2018 - 2030 (USD Million)
8.5.5 Argentina
8.5.5.1 Argentina Mycoplasma Testing Market, 2018 - 2030 (USD Million)
8.5.6 Rest of Latam
8.5.6.1 Rest of Latam Mycoplasma Testing Market, 2018 - 2030 (USD Million)
8.6 Middle East & Africa (MEA)
8.6.1 Middle East & Africa Swot Analysis
8.6.2 MEA Mycoplasma Testing Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.6.3 South Africa
8.6.3.1 South Africa Mycoplasma Testing Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.6.4 Saudi Arabia
8.6.4.1 Saudi Arabia Mycoplasma Testing Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.6.5 UAE
8.6.5.1 UAE Mycoplasma Testing Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.6.6 Rest of MEA
8.6.6.1 Rest of MEA Mycoplasma Testing Market Estimates And Forecast, 2018 - 2030 (USD Million)
CHAPTER 9 COMPETITIVE LANDSCAPE
9.1 Recent Developments & Impact Analysis, By Key Market Participants
9.2 Company Categorization
9.3 Vendor Landscape
9.3.1 List Of Key Distributors And Channel Partners
9.3.2 Company Market Share Analysis
9.4 Public Companies
9.4.1 Company Market Position Analysis
9.5 Private Companies
9.5.1 List Of Key Emerging Companies
9.5.2 Company Market Position Analysis
9.6 Regional Network Map
9.7 Company Profiles
9.7.1 THERMO FISHER SCIENTIFIC, INC.
9.7.1.1 Company overview
9.7.1.2 Financial performance
9.7.1.3 Product benchmarking
9.7.1.4 Strategic initiatives
9.7.2 MERCK KGAA
9.7.2.1 Company overview
9.7.2.2 Millipore Sigma
9.7.2.2.1 Company overview
9.7.2.3 Financial performance
9.7.2.4 Product benchmarking
9.7.2.5 Strategic initiatives
9.7.3 LONZA GROUP AG
9.7.3.1 Company overview
9.7.3.2 Financial performance
9.7.3.3 Product benchmarking
9.7.3.4 Strategic Initiatives
9.7.4 CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
9.7.4.1 Company overview
9.7.4.2 Financial performance
9.7.4.3 Product benchmarking
9.7.4.4 Strategic initiatives
9.7.5 PROMOCELL GMBH
9.7.5.1 Company overview
9.7.5.2 Product benchmarking
9.7.6 AMERICAN TYPE CULTURE COLLECTION
9.7.6.1 Company overview
9.7.6.2 Product benchmarking
9.7.6.3 Strategic initiatives
9.7.7 ASAHI KASEI MEDICAL CO., LTD.
9.7.7.1 Company overview
9.7.7.2 Bionique Testing Laboratories LLC
9.7.7.2.1 Company overview
9.7.7.2.2 Product benchmarking
9.7.7.2.3 Strategic initiatives
9.7.8 SARTORIUS AG
9.7.8.1 Company overview
9.7.8.2 Financial Performance
9.7.8.3 Product benchmarking
9.7.8.4 Strategic initiatives
9.7.9 INVIVOGEN
9.7.9.1 Company overview
9.7.9.2 Product benchmarking
9.7.10 EUROFINS SCIENTIFIC
9.7.10.1 Company overview
9.7.10.2 Financial Performance
9.7.10.3 Product benchmarking
9.7.10.4 Strategic initiatives
LIST OF TABLES
Table 1 List of key distributors and channel partners
Table 2 List of key emerging companies’/technology disruptors/innovators
Table 3 North America mycoplasma testing market, by countries, 2018 - 2030 (USD Million)
Table 4 North America mycoplasma testing market, by product, 2018 - 2030 (USD Million)
Table 5 North America mycoplasma testing market, by kits & reagents, 2018 - 2030 (USD Million)
Table 6 North America mycoplasma testing market, by technology, 2018 - 2030 (USD Million)
Table 7 North America mycoplasma testing market, by application, 2018 - 2030 (USD Million)
Table 8 North America mycoplasma testing market, by end use, 2018 - 2030 (USD Million)
Table 9 U.S. mycoplasma testing market, by product, 2018 - 2030 (USD Million)
Table 10 U.S. mycoplasma testing market, by kits & reagents, 2018 - 2030 (USD Million)
Table 11 U.S. mycoplasma testing market, by technology, 2018 - 2030 (USD Million)
Table 12 U.S. mycoplasma testing market, by application, 2018 - 2030 (USD Million)
Table 13 U.S. mycoplasma testing market, by end use, 2018 - 2030 (USD Million)
Table 14 Canada mycoplasma testing market, by product, 2018 - 2030 (USD Million)
Table 15 Canada mycoplasma testing market, by kits & reagents, 2018 - 2030 (USD Million)
Table 16 Canada mycoplasma testing market, by technology, 2018 - 2030 (USD Million)
Table 17 Canada mycoplasma testing market, by application, 2018 - 2030 (USD Million)
Table 18 Canada mycoplasma testing market, by end use, 2018 - 2030 (USD Million)
Table 19 Europe mycoplasma testing market, by countries, 2018 - 2030 (USD Million)
Table 20 Europe mycoplasma testing market, by product, 2018 - 2030 (USD Million)
Table 21 Europe mycoplasma testing market, by kits & reagents, 2018 - 2030 (USD Million)
Table 22 Europe mycoplasma testing market, by technology, 2018 - 2030 (USD Million)
Table 23 Europe mycoplasma testing market, by application, 2018 - 2030 (USD Million)
Table 24 Europe mycoplasma testing market, by end use, 2018 - 2030 (USD Million)
Table 25 Germany mycoplasma testing market, by product, 2018 - 2030 (USD Million)
Table 26 Germany mycoplasma testing market, by kits & reagents, 2018 - 2030 (USD Million)
Table 27 Germany mycoplasma testing market, by technology, 2018 - 2030 (USD Million)
Table 28 Germany mycoplasma testing market, by application, 2018 - 2030 (USD Million)
Table 29 Germany mycoplasma testing market, by end use, 2018 - 2030 (USD Million)
Table 30 U.K. mycoplasma testing market, by product, 2018 - 2030 (USD Million)
Table 31 U.K. mycoplasma testing market, by kits & reagents, 2018 - 2030 (USD Million)
Table 32 U.K. mycoplasma testing market, by technology, 2018 - 2030 (USD Million)
Table 33 U.K. mycoplasma testing market, by application, 2018 - 2030 (USD Million)
Table 34 U.K. mycoplasma testing market, by end use, 2018 - 2030 (USD Million)
Table 35 France mycoplasma testing market, by product, 2018 - 2030 (USD Million)
Table 36 France mycoplasma testing market, by kits & reagents, 2018 - 2030 (USD Million)
Table 37 France mycoplasma testing market, by technology, 2018 - 2030 (USD Million)
Table 38 France mycoplasma testing market, by application, 2018 - 2030 (USD Million)
Table 39 France mycoplasma testing market, by end use, 2018 - 2030 (USD Million)
Table 40 Italy mycoplasma testing market, by product, 2018 - 2030 (USD Million)
Table 41 Italy mycoplasma testing market, by kits & reagents, 2018 - 2030 (USD Million)
Table 42 Italy mycoplasma testing market, by technology, 2018 - 2030 (USD Million)
Table 43 Italy mycoplasma testing market, by application, 2018 - 2030 (USD Million)
Table 44 Italy mycoplasma testing market, by end use, 2018 - 2030 (USD Million)
Table 45 Spain mycoplasma testing market, by product, 2018 - 2030 (USD Million)
Table 46 Spain mycoplasma testing market, by kits & reagents, 2018 - 2030 (USD Million)
Table 47 Spain mycoplasma testing market, by technology, 2018 - 2030 (USD Million)
Table 48 Spain mycoplasma testing market, by application, 2018 - 2030 (USD Million)
Table 49 Spain mycoplasma testing market, by end use, 2018 - 2030 (USD Million)
Table 50 Russia mycoplasma testing market, by product, 2018 - 2030 (USD Million)
Table 51 Russia mycoplasma testing market, by kits & reagents, 2018 - 2030 (USD Million)
Table 52 Russia mycoplasma testing market, by technology, 2018 - 2030 (USD Million)
Table 53 Russia mycoplasma testing market, by application, 2018 - 2030 (USD Million)
Table 54 Russia mycoplasma testing market, by end use, 2018 - 2030 (USD Million)
Table 55 Asia Pacific mycoplasma testing market, by countries, 2018 - 2030 (USD Million)
Table 56 Asia Pacific mycoplasma testing market, by product, 2018 - 2030 (USD Million)
Table 57 Asia Pacific mycoplasma testing market, by kits & reagents, 2018 - 2030 (USD Million)
Table 58 Asia Pacific mycoplasma testing market, by technology, 2018 - 2030 (USD Million)
Table 59 Asia Pacific mycoplasma testing market, by application, 2018 - 2030 (USD Million)
Table 60 Asia Pacific mycoplasma testing market, by end use, 2018 - 2030 (USD Million)
Table 61 Japan mycoplasma testing market, by product, 2018 - 2030 (USD Million)
Table 62 Japan mycoplasma testing market, by kits & reagents, 2018 - 2030 (USD Million)
Table 63 Japan mycoplasma testing market, by technology, 2018 - 2030 (USD Million)
Table 64 Japan mycoplasma testing market, by application, 2018 - 2030 (USD Million)
Table 65 Japan mycoplasma testing market, by end use, 2018 - 2030 (USD Million)
Table 66 China mycoplasma testing market, by product, 2018 - 2030 (USD Million)
Table 67 China mycoplasma testing market, by kits & reagents, 2018 - 2030 (USD Million)
Table 68 China mycoplasma testing market, by technology, 2018 - 2030 (USD Million)
Table 69 China mycoplasma testing market, by application, 2018 - 2030 (USD Million)
Table 70 China mycoplasma testing market, by end use, 2018 - 2030 (USD Million)
Table 71 India mycoplasma testing market, by product, 2018 - 2030 (USD Million)
Table 72 India mycoplasma testing market, by kits & reagents, 2018 - 2030 (USD Million)
Table 73 India mycoplasma testing market, by technology, 2018 - 2030 (USD Million)
Table 74 India mycoplasma testing market, by application, 2018 - 2030 (USD Million)
Table 75 India mycoplasma testing market, by end use, 2018 - 2030 (USD Million)
Table 76 Australia mycoplasma testing market, by product, 2018 - 2030 (USD Million)
Table 77 Australia mycoplasma testing market, by kits & reagents, 2018 - 2030 (USD Million)
Table 78 Australia mycoplasma testing market, by technology, 2018 - 2030 (USD Million)
Table 79 Australia mycoplasma testing market, by application, 2018 - 2030 (USD Million)
Table 80 Australia mycoplasma testing market, by end use, 2018 - 2030 (USD Million)
Table 81 South Korea mycoplasma testing market, by product, 2018 - 2030 (USD Million)
Table 82 South Korea mycoplasma testing market, by kits & reagents, 2018 - 2030 (USD Million)
Table 83 South Korea mycoplasma testing market, by technology, 2018 - 2030 (USD Million)
Table 84 South Korea mycoplasma testing market, by application, 2018 - 2030 (USD Million)
Table 85 South Korea mycoplasma testing market, by end use, 2018 - 2030 (USD Million)
Table 86 Singapore mycoplasma testing market, by product, 2018 - 2030 (USD Million)
Table 87 Singapore mycoplasma testing market, by kits & reagents, 2018 - 2030 (USD Million)
Table 88 Singapore mycoplasma testing market, by technology, 2018 - 2030 (USD Million)
Table 89 Singapore mycoplasma testing market, by application, 2018 - 2030 (USD Million)
Table 90 Singapore mycoplasma testing market, by end use, 2018 - 2030 (USD Million)
Table 91 Latin America mycoplasma testing market, by countries, 2018 - 2030 (USD Million)
Table 92 Latin America mycoplasma testing market, by product, 2018 - 2030 (USD Million)
Table 93 Latin America mycoplasma testing market, by kits & reagents, 2018 - 2030 (USD Million)
Table 94 Latin America mycoplasma testing market, by technology, 2018 - 2030 (USD Million)
Table 95 Latin America mycoplasma testing market, by application, 2018 - 2030 (USD Million)
Table 96 Latin America mycoplasma testing market, by end use, 2018 - 2030 (USD Million)
Table 97 Brazil mycoplasma testing market, by product, 2018 - 2030 (USD Million)
Table 98 Brazil mycoplasma testing market, by kits & reagents, 2018 - 2030 (USD Million)
Table 99 Brazil mycoplasma testing market, by technology, 2018 - 2030 (USD Million)
Table 100 Brazil mycoplasma testing market, by application, 2018 - 2030 (USD Million)
Table 101 Brazil mycoplasma testing market, by end use, 2018 - 2030 (USD Million)
Table 102 Mexico mycoplasma testing market, by product, 2018 - 2030 (USD Million)
Table 103 Mexico mycoplasma testing market, by kits & reagents, 2018 - 2030 (USD Million)
Table 104 Mexico mycoplasma testing market, by technology, 2018 - 2030 (USD Million)
Table 105 Mexico mycoplasma testing market, by application, 2018 - 2030 (USD Million)
Table 106 Mexico mycoplasma testing market, by end use, 2018 - 2030 (USD Million)
Table 107 Argentina mycoplasma testing market, by product, 2018 - 2030 (USD Million)
Table 108 Argentina mycoplasma testing market, by kits & reagents, 2018 - 2030 (USD Million)
Table 109 Argentina mycoplasma testing market, by technology, 2018 - 2030 (USD Million)
Table 110 Argentina mycoplasma testing market, by application, 2018 - 2030 (USD Million)
Table 111 Argentina mycoplasma testing market, by end use, 2018 - 2030 (USD Million)
Table 112 MEA mycoplasma testing market, by product, 2018 - 2030 (USD Million)
Table 113 MEA mycoplasma testing market, by product, 2018 - 2030 (USD Million)
Table 114 MEA mycoplasma testing market, by kits & reagents, 2018 - 2030 (USD Million)
Table 115 MEA mycoplasma testing market, by technology, 2018 - 2030 (USD Million)
Table 116 MEA mycoplasma testing market, by application, 2018 - 2030 (USD Million)
Table 117 MEA mycoplasma testing market, by end use, 2018 - 2030 (USD Million)
Table 118 South Africa mycoplasma testing market, by product, 2018 - 2030 (USD Million)
Table 119 South Africa mycoplasma testing market, by kits & reagents, 2018 - 2030 (USD Million)
Table 120 South Africa mycoplasma testing market, by technology, 2018 - 2030 (USD Million)
Table 121 South Africa mycoplasma testing market, by application, 2018 - 2030 (USD Million)
Table 122 South Africa mycoplasma testing market, by end use, 2018 - 2030 (USD Million)
Table 123 Saudi Arabia mycoplasma testing market, by product, 2018 - 2030 (USD Million)
Table 124 Saudi Arabia mycoplasma testing market, by kits & reagents, 2018 - 2030 (USD Million)
Table 125 Saudi Arabia mycoplasma testing market, by technology, 2018 - 2030 (USD Million)
Table 126 Saudi Arabia mycoplasma testing market, by application, 2018 - 2030 (USD Million)
Table 127 Saudi Arabia mycoplasma testing market, by end use, 2018 - 2030 (USD Million)
Table 128 UAE mycoplasma testing market, by product, 2018 - 2030 (USD Million)
Table 129 UAE mycoplasma testing market, by kits & reagents, 2018 - 2030 (USD Million)
Table 130 UAE mycoplasma testing market, by technology, 2018 - 2030 (USD Million)
Table 131 UAE mycoplasma testing market, by application, 2018 - 2030 (USD Million)
Table 132 UAE mycoplasma testing market, by end use, 2018 - 2030 (USD Million)
Table 1 List of key distributors and channel partners
Table 2 List of key emerging companies’/technology disruptors/innovators
Table 3 North America mycoplasma testing market, by countries, 2018 - 2030 (USD Million)
Table 4 North America mycoplasma testing market, by product, 2018 - 2030 (USD Million)
Table 5 North America mycoplasma testing market, by kits & reagents, 2018 - 2030 (USD Million)
Table 6 North America mycoplasma testing market, by technology, 2018 - 2030 (USD Million)
Table 7 North America mycoplasma testing market, by application, 2018 - 2030 (USD Million)
Table 8 North America mycoplasma testing market, by end use, 2018 - 2030 (USD Million)
Table 9 U.S. mycoplasma testing market, by product, 2018 - 2030 (USD Million)
Table 10 U.S. mycoplasma testing market, by kits & reagents, 2018 - 2030 (USD Million)
Table 11 U.S. mycoplasma testing market, by technology, 2018 - 2030 (USD Million)
Table 12 U.S. mycoplasma testing market, by application, 2018 - 2030 (USD Million)
Table 13 U.S. mycoplasma testing market, by end use, 2018 - 2030 (USD Million)
Table 14 Canada mycoplasma testing market, by product, 2018 - 2030 (USD Million)
Table 15 Canada mycoplasma testing market, by kits & reagents, 2018 - 2030 (USD Million)
Table 16 Canada mycoplasma testing market, by technology, 2018 - 2030 (USD Million)
Table 17 Canada mycoplasma testing market, by application, 2018 - 2030 (USD Million)
Table 18 Canada mycoplasma testing market, by end use, 2018 - 2030 (USD Million)
Table 19 Europe mycoplasma testing market, by countries, 2018 - 2030 (USD Million)
Table 20 Europe mycoplasma testing market, by product, 2018 - 2030 (USD Million)
Table 21 Europe mycoplasma testing market, by kits & reagents, 2018 - 2030 (USD Million)
Table 22 Europe mycoplasma testing market, by technology, 2018 - 2030 (USD Million)
Table 23 Europe mycoplasma testing market, by application, 2018 - 2030 (USD Million)
Table 24 Europe mycoplasma testing market, by end use, 2018 - 2030 (USD Million)
Table 25 Germany mycoplasma testing market, by product, 2018 - 2030 (USD Million)
Table 26 Germany mycoplasma testing market, by kits & reagents, 2018 - 2030 (USD Million)
Table 27 Germany mycoplasma testing market, by technology, 2018 - 2030 (USD Million)
Table 28 Germany mycoplasma testing market, by application, 2018 - 2030 (USD Million)
Table 29 Germany mycoplasma testing market, by end use, 2018 - 2030 (USD Million)
Table 30 U.K. mycoplasma testing market, by product, 2018 - 2030 (USD Million)
Table 31 U.K. mycoplasma testing market, by kits & reagents, 2018 - 2030 (USD Million)
Table 32 U.K. mycoplasma testing market, by technology, 2018 - 2030 (USD Million)
Table 33 U.K. mycoplasma testing market, by application, 2018 - 2030 (USD Million)
Table 34 U.K. mycoplasma testing market, by end use, 2018 - 2030 (USD Million)
Table 35 France mycoplasma testing market, by product, 2018 - 2030 (USD Million)
Table 36 France mycoplasma testing market, by kits & reagents, 2018 - 2030 (USD Million)
Table 37 France mycoplasma testing market, by technology, 2018 - 2030 (USD Million)
Table 38 France mycoplasma testing market, by application, 2018 - 2030 (USD Million)
Table 39 France mycoplasma testing market, by end use, 2018 - 2030 (USD Million)
Table 40 Italy mycoplasma testing market, by product, 2018 - 2030 (USD Million)
Table 41 Italy mycoplasma testing market, by kits & reagents, 2018 - 2030 (USD Million)
Table 42 Italy mycoplasma testing market, by technology, 2018 - 2030 (USD Million)
Table 43 Italy mycoplasma testing market, by application, 2018 - 2030 (USD Million)
Table 44 Italy mycoplasma testing market, by end use, 2018 - 2030 (USD Million)
Table 45 Spain mycoplasma testing market, by product, 2018 - 2030 (USD Million)
Table 46 Spain mycoplasma testing market, by kits & reagents, 2018 - 2030 (USD Million)
Table 47 Spain mycoplasma testing market, by technology, 2018 - 2030 (USD Million)
Table 48 Spain mycoplasma testing market, by application, 2018 - 2030 (USD Million)
Table 49 Spain mycoplasma testing market, by end use, 2018 - 2030 (USD Million)
Table 50 Russia mycoplasma testing market, by product, 2018 - 2030 (USD Million)
Table 51 Russia mycoplasma testing market, by kits & reagents, 2018 - 2030 (USD Million)
Table 52 Russia mycoplasma testing market, by technology, 2018 - 2030 (USD Million)
Table 53 Russia mycoplasma testing market, by application, 2018 - 2030 (USD Million)
Table 54 Russia mycoplasma testing market, by end use, 2018 - 2030 (USD Million)
Table 55 Asia Pacific mycoplasma testing market, by countries, 2018 - 2030 (USD Million)
Table 56 Asia Pacific mycoplasma testing market, by product, 2018 - 2030 (USD Million)
Table 57 Asia Pacific mycoplasma testing market, by kits & reagents, 2018 - 2030 (USD Million)
Table 58 Asia Pacific mycoplasma testing market, by technology, 2018 - 2030 (USD Million)
Table 59 Asia Pacific mycoplasma testing market, by application, 2018 - 2030 (USD Million)
Table 60 Asia Pacific mycoplasma testing market, by end use, 2018 - 2030 (USD Million)
Table 61 Japan mycoplasma testing market, by product, 2018 - 2030 (USD Million)
Table 62 Japan mycoplasma testing market, by kits & reagents, 2018 - 2030 (USD Million)
Table 63 Japan mycoplasma testing market, by technology, 2018 - 2030 (USD Million)
Table 64 Japan mycoplasma testing market, by application, 2018 - 2030 (USD Million)
Table 65 Japan mycoplasma testing market, by end use, 2018 - 2030 (USD Million)
Table 66 China mycoplasma testing market, by product, 2018 - 2030 (USD Million)
Table 67 China mycoplasma testing market, by kits & reagents, 2018 - 2030 (USD Million)
Table 68 China mycoplasma testing market, by technology, 2018 - 2030 (USD Million)
Table 69 China mycoplasma testing market, by application, 2018 - 2030 (USD Million)
Table 70 China mycoplasma testing market, by end use, 2018 - 2030 (USD Million)
Table 71 India mycoplasma testing market, by product, 2018 - 2030 (USD Million)
Table 72 India mycoplasma testing market, by kits & reagents, 2018 - 2030 (USD Million)
Table 73 India mycoplasma testing market, by technology, 2018 - 2030 (USD Million)
Table 74 India mycoplasma testing market, by application, 2018 - 2030 (USD Million)
Table 75 India mycoplasma testing market, by end use, 2018 - 2030 (USD Million)
Table 76 Australia mycoplasma testing market, by product, 2018 - 2030 (USD Million)
Table 77 Australia mycoplasma testing market, by kits & reagents, 2018 - 2030 (USD Million)
Table 78 Australia mycoplasma testing market, by technology, 2018 - 2030 (USD Million)
Table 79 Australia mycoplasma testing market, by application, 2018 - 2030 (USD Million)
Table 80 Australia mycoplasma testing market, by end use, 2018 - 2030 (USD Million)
Table 81 South Korea mycoplasma testing market, by product, 2018 - 2030 (USD Million)
Table 82 South Korea mycoplasma testing market, by kits & reagents, 2018 - 2030 (USD Million)
Table 83 South Korea mycoplasma testing market, by technology, 2018 - 2030 (USD Million)
Table 84 South Korea mycoplasma testing market, by application, 2018 - 2030 (USD Million)
Table 85 South Korea mycoplasma testing market, by end use, 2018 - 2030 (USD Million)
Table 86 Singapore mycoplasma testing market, by product, 2018 - 2030 (USD Million)
Table 87 Singapore mycoplasma testing market, by kits & reagents, 2018 - 2030 (USD Million)
Table 88 Singapore mycoplasma testing market, by technology, 2018 - 2030 (USD Million)
Table 89 Singapore mycoplasma testing market, by application, 2018 - 2030 (USD Million)
Table 90 Singapore mycoplasma testing market, by end use, 2018 - 2030 (USD Million)
Table 91 Latin America mycoplasma testing market, by countries, 2018 - 2030 (USD Million)
Table 92 Latin America mycoplasma testing market, by product, 2018 - 2030 (USD Million)
Table 93 Latin America mycoplasma testing market, by kits & reagents, 2018 - 2030 (USD Million)
Table 94 Latin America mycoplasma testing market, by technology, 2018 - 2030 (USD Million)
Table 95 Latin America mycoplasma testing market, by application, 2018 - 2030 (USD Million)
Table 96 Latin America mycoplasma testing market, by end use, 2018 - 2030 (USD Million)
Table 97 Brazil mycoplasma testing market, by product, 2018 - 2030 (USD Million)
Table 98 Brazil mycoplasma testing market, by kits & reagents, 2018 - 2030 (USD Million)
Table 99 Brazil mycoplasma testing market, by technology, 2018 - 2030 (USD Million)
Table 100 Brazil mycoplasma testing market, by application, 2018 - 2030 (USD Million)
Table 101 Brazil mycoplasma testing market, by end use, 2018 - 2030 (USD Million)
Table 102 Mexico mycoplasma testing market, by product, 2018 - 2030 (USD Million)
Table 103 Mexico mycoplasma testing market, by kits & reagents, 2018 - 2030 (USD Million)
Table 104 Mexico mycoplasma testing market, by technology, 2018 - 2030 (USD Million)
Table 105 Mexico mycoplasma testing market, by application, 2018 - 2030 (USD Million)
Table 106 Mexico mycoplasma testing market, by end use, 2018 - 2030 (USD Million)
Table 107 Argentina mycoplasma testing market, by product, 2018 - 2030 (USD Million)
Table 108 Argentina mycoplasma testing market, by kits & reagents, 2018 - 2030 (USD Million)
Table 109 Argentina mycoplasma testing market, by technology, 2018 - 2030 (USD Million)
Table 110 Argentina mycoplasma testing market, by application, 2018 - 2030 (USD Million)
Table 111 Argentina mycoplasma testing market, by end use, 2018 - 2030 (USD Million)
Table 112 MEA mycoplasma testing market, by product, 2018 - 2030 (USD Million)
Table 113 MEA mycoplasma testing market, by product, 2018 - 2030 (USD Million)
Table 114 MEA mycoplasma testing market, by kits & reagents, 2018 - 2030 (USD Million)
Table 115 MEA mycoplasma testing market, by technology, 2018 - 2030 (USD Million)
Table 116 MEA mycoplasma testing market, by application, 2018 - 2030 (USD Million)
Table 117 MEA mycoplasma testing market, by end use, 2018 - 2030 (USD Million)
Table 118 South Africa mycoplasma testing market, by product, 2018 - 2030 (USD Million)
Table 119 South Africa mycoplasma testing market, by kits & reagents, 2018 - 2030 (USD Million)
Table 120 South Africa mycoplasma testing market, by technology, 2018 - 2030 (USD Million)
Table 121 South Africa mycoplasma testing market, by application, 2018 - 2030 (USD Million)
Table 122 South Africa mycoplasma testing market, by end use, 2018 - 2030 (USD Million)
Table 123 Saudi Arabia mycoplasma testing market, by product, 2018 - 2030 (USD Million)
Table 124 Saudi Arabia mycoplasma testing market, by kits & reagents, 2018 - 2030 (USD Million)
Table 125 Saudi Arabia mycoplasma testing market, by technology, 2018 - 2030 (USD Million)
Table 126 Saudi Arabia mycoplasma testing market, by application, 2018 - 2030 (USD Million)
Table 127 Saudi Arabia mycoplasma testing market, by end use, 2018 - 2030 (USD Million)
Table 128 UAE mycoplasma testing market, by product, 2018 - 2030 (USD Million)
Table 129 UAE mycoplasma testing market, by kits & reagents, 2018 - 2030 (USD Million)
Table 130 UAE mycoplasma testing market, by technology, 2018 - 2030 (USD Million)
Table 131 UAE mycoplasma testing market, by application, 2018 - 2030 (USD Million)
Table 132 UAE mycoplasma testing market, by end use, 2018 - 2030 (USD Million)
LIST OF FIGURES
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Commodity flow analysis
Fig. 9 Volume price analysis
Fig. 10 Market summary, 2021 (USD Million)
Fig. 11 Parent market outlook
Fig. 12 Penetration & growth prospect mapping, by product
Fig. 13 Penetration & growth prospect mapping, by technology
Fig. 14 Penetration & growth prospect mapping, by application
Fig. 15 Penetration & growth prospect mapping, by end-use
Fig. 16 Market trends and outlook
Fig. 17 Mycoplasma testing market driver impact
Fig. 18 Mycoplasma contamination impact
Fig. 19 Mycoplasma testing market restraint impact
Fig. 20 Porter’s five force analysis
Fig. 21 SWOT analysis, by factor (political & legal, economic and technological)
Fig. 22 Sex distribution of pediatric patients with mycoplasma pneumoniae infection between January 2017 and December 2020
Fig. 23 Mycoplasma Testing Market: Product Outlook and Key Takeaways
Fig. 24 Mycoplasma Testing Market: Product Movement Analysis
Fig. 25 Global Instruments Market, 2018 - 2030 (USD million)
Fig. 26 Global Kits & Reagents Market, 2018 - 2030 (USD million)
Fig. 27 Global PCR Assays Market, 2018 - 2030 (USD million)
Fig. 28 Global Nucleic Acid Detection Kits Market, 2018 - 2030 (USD million)
Fig. 29 Global Stains Market, 2018 - 2030 (USD million)
Fig. 30 Global Elimination Kits Market, 2018 - 2030 (USD million)
Fig. 31 Global Standards & Controls Market, 2018 - 2030 (USD million)
Fig. 32 Global Other Kits & Reagents Market, 2018 - 2030 (USD million)
Fig. 33 Global Services Market, 2018 - 2030 (USD million)
Fig. 34 Mycoplasma Testing Market: Technology Outlook and Key Takeaways
Fig. 35 Mycoplasma Testing Market: Technology Movement Analysis
Fig. 36 Global PCR Market, 2018 - 2030 (USD million)
Fig. 37 Global ELISA Market, 2018 - 2030 (USD million)
Fig. 38 Global Direct Assays Market, 2018 - 2030 (USD million)
Fig. 39 Global Indirect Assays Market, 2018 - 2030 (USD million)
Fig. 40 Global Microbial Culture Techniques Market, 2018 - 2030 (USD million)
Fig. 41 Global Enzymatic Methods Market, 2018 - 2030 (USD million)
Fig. 42 Mycoplasma Testing Market: Application Outlook and Key Takeaways
Fig. 43 Mycoplasma Testing Market: Application Movement Analysis
Fig. 44 Global Cell Line Testing Market, 2018 - 2030 (USD million)
Fig. 45 Global Virus Testing Market, 2018 - 2030 (USD million)
Fig. 46 Global End-of-Production Cell Testing Market, 2018 - 2030 (USD million)
Fig. 47 Global Other Applications Market, 2018 - 2030 (USD million)
Fig. 48 Mycoplasma Testing Market: End-Use Outlook and Key Takeaways
Fig. 49 Mycoplasma Testing Market: End-Use Movement Analysis
Fig. 50 Global Mycoplasma Testing Market for Pharmaceutical & Biotechnology Companies, 2018 - 2030 (USD million)
Fig. 51 Global Mycoplasma Testing Market for Cell Banks, 2018 - 2030 (USD million)
Fig. 52 Global Mycoplasma Testing Market for Contract Research Organizations (CROs), 2018 - 2030 (USD million)
Fig. 53 Global Mycoplasma Testing Market for Academic & Research Institutes, 2018 - 2030 (USD million)
Fig. 54 Global Mycoplasma Testing Market for Other End-use, 2018 - 2030 (USD million)
Fig. 55 Mycoplasma testing: Regional outlook and key takeaways
Fig. 56 Mycoplasma testing market: Regional movement analysis
Fig. 57 North America mycoplasma testing market, SWOT analysis
Fig. 58 North America mycoplasma testing market, 2018 - 2030 (USD million)
Fig. 59 U.S. mycoplasma testing market, 2018 - 2030 (USD million)
Fig. 60 Canada mycoplasma testing market, 2018 - 2030 (USD million)
Fig. 61 Europe mycoplasma testing market SWOT analysis
Fig. 62 Europe mycoplasma testing market estimates and forecast, 2018 - 2030 (USD million)
Fig. 63 Germany mycoplasma testing market estimates and forecast, 2018 - 2030 (USD million)
Fig. 64 U.K. mycoplasma testing market estimates and forecast, 2018 - 2030 (USD million)
Fig. 65 France mycoplasma testing market estimates and forecast, 2018 - 2030 (USD million)
Fig. 66 Italy mycoplasma testing market estimates and forecast, 2018 - 2030 (USD million)
Fig. 67 Spain mycoplasma testing market estimates and forecast, 2018 - 2030 (USD million)
Fig. 68 Russia mycoplasma testing market estimates and forecast, 2018 - 2030 (USD million)
Fig. 69 Asia Pacific mycoplasma testing market SWOT analysis
Fig. 70 Asia Pacific mycoplasma testing market estimates and forecast, 2018 - 2030 (USD million)
Fig. 71 Japan mycoplasma testing market estimates and forecast, 2018 - 2030 (USD million)
Fig. 72 China mycoplasma testing market estimates and forecast, 2018 - 2030 (USD million)
Fig. 73 India mycoplasma testing market estimates and forecast, 2018 - 2030 (USD million)
Fig. 74 South Korea mycoplasma testing market estimates and forecast, 2018 - 2030 (USD million)
Fig. 75 Australia mycoplasma testing market estimates and forecast, 2018 - 2030 (USD million)
Fig. 76 Singapore mycoplasma testing market estimates and forecast, 2018 - 2030 (USD million)
Fig. 77 Latin America mycoplasma testing market SWOT analysis
Fig. 78 Latin America mycoplasma testing market estimates and forecast, 2018 - 2030 (USD million)
Fig. 79 Brazil mycoplasma testing market estimates and forecast, 2018 - 2030 (USD million)
Fig. 80 Mexico mycoplasma testing market estimates and forecast, 2018 - 2030 (USD million)
Fig. 81 Argentina mycoplasma testing market estimates and forecast, 2018 - 2030 (USD million)
Fig. 82 MEA mycoplasma testing market SWOT analysis
Fig. 83 MEA mycoplasma testing market estimates and forecast, 2018 - 2030 (USD million)
Fig. 84 South Africa mycoplasma testing market estimates and forecast, 2018 - 2030 (USD million)
Fig. 85 Saudi Arabia mycoplasma testing market estimates and forecast, 2018 - 2030 (USD million)
Fig. 86 UAE mycoplasma testing market estimates and forecast, 2018 - 2030 (USD million)
Fig. 87 Heat map analysis, by key market participants
Fig. 88 Company categorization - Mycoplasma testing market
Fig. 89 Company market share analysis for mycoplasma testing market (2021)
Fig. 90 Public company market position analysis, 2021
Fig. 91 Private company market position analysis, 2021
Fig. 92 Regional network map
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Commodity flow analysis
Fig. 9 Volume price analysis
Fig. 10 Market summary, 2021 (USD Million)
Fig. 11 Parent market outlook
Fig. 12 Penetration & growth prospect mapping, by product
Fig. 13 Penetration & growth prospect mapping, by technology
Fig. 14 Penetration & growth prospect mapping, by application
Fig. 15 Penetration & growth prospect mapping, by end-use
Fig. 16 Market trends and outlook
Fig. 17 Mycoplasma testing market driver impact
Fig. 18 Mycoplasma contamination impact
Fig. 19 Mycoplasma testing market restraint impact
Fig. 20 Porter’s five force analysis
Fig. 21 SWOT analysis, by factor (political & legal, economic and technological)
Fig. 22 Sex distribution of pediatric patients with mycoplasma pneumoniae infection between January 2017 and December 2020
Fig. 23 Mycoplasma Testing Market: Product Outlook and Key Takeaways
Fig. 24 Mycoplasma Testing Market: Product Movement Analysis
Fig. 25 Global Instruments Market, 2018 - 2030 (USD million)
Fig. 26 Global Kits & Reagents Market, 2018 - 2030 (USD million)
Fig. 27 Global PCR Assays Market, 2018 - 2030 (USD million)
Fig. 28 Global Nucleic Acid Detection Kits Market, 2018 - 2030 (USD million)
Fig. 29 Global Stains Market, 2018 - 2030 (USD million)
Fig. 30 Global Elimination Kits Market, 2018 - 2030 (USD million)
Fig. 31 Global Standards & Controls Market, 2018 - 2030 (USD million)
Fig. 32 Global Other Kits & Reagents Market, 2018 - 2030 (USD million)
Fig. 33 Global Services Market, 2018 - 2030 (USD million)
Fig. 34 Mycoplasma Testing Market: Technology Outlook and Key Takeaways
Fig. 35 Mycoplasma Testing Market: Technology Movement Analysis
Fig. 36 Global PCR Market, 2018 - 2030 (USD million)
Fig. 37 Global ELISA Market, 2018 - 2030 (USD million)
Fig. 38 Global Direct Assays Market, 2018 - 2030 (USD million)
Fig. 39 Global Indirect Assays Market, 2018 - 2030 (USD million)
Fig. 40 Global Microbial Culture Techniques Market, 2018 - 2030 (USD million)
Fig. 41 Global Enzymatic Methods Market, 2018 - 2030 (USD million)
Fig. 42 Mycoplasma Testing Market: Application Outlook and Key Takeaways
Fig. 43 Mycoplasma Testing Market: Application Movement Analysis
Fig. 44 Global Cell Line Testing Market, 2018 - 2030 (USD million)
Fig. 45 Global Virus Testing Market, 2018 - 2030 (USD million)
Fig. 46 Global End-of-Production Cell Testing Market, 2018 - 2030 (USD million)
Fig. 47 Global Other Applications Market, 2018 - 2030 (USD million)
Fig. 48 Mycoplasma Testing Market: End-Use Outlook and Key Takeaways
Fig. 49 Mycoplasma Testing Market: End-Use Movement Analysis
Fig. 50 Global Mycoplasma Testing Market for Pharmaceutical & Biotechnology Companies, 2018 - 2030 (USD million)
Fig. 51 Global Mycoplasma Testing Market for Cell Banks, 2018 - 2030 (USD million)
Fig. 52 Global Mycoplasma Testing Market for Contract Research Organizations (CROs), 2018 - 2030 (USD million)
Fig. 53 Global Mycoplasma Testing Market for Academic & Research Institutes, 2018 - 2030 (USD million)
Fig. 54 Global Mycoplasma Testing Market for Other End-use, 2018 - 2030 (USD million)
Fig. 55 Mycoplasma testing: Regional outlook and key takeaways
Fig. 56 Mycoplasma testing market: Regional movement analysis
Fig. 57 North America mycoplasma testing market, SWOT analysis
Fig. 58 North America mycoplasma testing market, 2018 - 2030 (USD million)
Fig. 59 U.S. mycoplasma testing market, 2018 - 2030 (USD million)
Fig. 60 Canada mycoplasma testing market, 2018 - 2030 (USD million)
Fig. 61 Europe mycoplasma testing market SWOT analysis
Fig. 62 Europe mycoplasma testing market estimates and forecast, 2018 - 2030 (USD million)
Fig. 63 Germany mycoplasma testing market estimates and forecast, 2018 - 2030 (USD million)
Fig. 64 U.K. mycoplasma testing market estimates and forecast, 2018 - 2030 (USD million)
Fig. 65 France mycoplasma testing market estimates and forecast, 2018 - 2030 (USD million)
Fig. 66 Italy mycoplasma testing market estimates and forecast, 2018 - 2030 (USD million)
Fig. 67 Spain mycoplasma testing market estimates and forecast, 2018 - 2030 (USD million)
Fig. 68 Russia mycoplasma testing market estimates and forecast, 2018 - 2030 (USD million)
Fig. 69 Asia Pacific mycoplasma testing market SWOT analysis
Fig. 70 Asia Pacific mycoplasma testing market estimates and forecast, 2018 - 2030 (USD million)
Fig. 71 Japan mycoplasma testing market estimates and forecast, 2018 - 2030 (USD million)
Fig. 72 China mycoplasma testing market estimates and forecast, 2018 - 2030 (USD million)
Fig. 73 India mycoplasma testing market estimates and forecast, 2018 - 2030 (USD million)
Fig. 74 South Korea mycoplasma testing market estimates and forecast, 2018 - 2030 (USD million)
Fig. 75 Australia mycoplasma testing market estimates and forecast, 2018 - 2030 (USD million)
Fig. 76 Singapore mycoplasma testing market estimates and forecast, 2018 - 2030 (USD million)
Fig. 77 Latin America mycoplasma testing market SWOT analysis
Fig. 78 Latin America mycoplasma testing market estimates and forecast, 2018 - 2030 (USD million)
Fig. 79 Brazil mycoplasma testing market estimates and forecast, 2018 - 2030 (USD million)
Fig. 80 Mexico mycoplasma testing market estimates and forecast, 2018 - 2030 (USD million)
Fig. 81 Argentina mycoplasma testing market estimates and forecast, 2018 - 2030 (USD million)
Fig. 82 MEA mycoplasma testing market SWOT analysis
Fig. 83 MEA mycoplasma testing market estimates and forecast, 2018 - 2030 (USD million)
Fig. 84 South Africa mycoplasma testing market estimates and forecast, 2018 - 2030 (USD million)
Fig. 85 Saudi Arabia mycoplasma testing market estimates and forecast, 2018 - 2030 (USD million)
Fig. 86 UAE mycoplasma testing market estimates and forecast, 2018 - 2030 (USD million)
Fig. 87 Heat map analysis, by key market participants
Fig. 88 Company categorization - Mycoplasma testing market
Fig. 89 Company market share analysis for mycoplasma testing market (2021)
Fig. 90 Public company market position analysis, 2021
Fig. 91 Private company market position analysis, 2021
Fig. 92 Regional network map
